These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 26728730

  • 1. Alkyl 2-arylhydrazinylidene-3-oxo-3-polyfluoroalkylpropionates as new effective and selective inhibitors of carboxylesterase.
    Boltneva NP, Makhaeva GF, Kovaleva NV, Lushchekina SV, Burgart YV, Shchegol'kov EV, Saloutin VI, Chupakhin ON.
    Dokl Biochem Biophys; 2015; 465():381-5. PubMed ID: 26728730
    [Abstract] [Full Text] [Related]

  • 2. Synthesis, molecular docking and biological evaluation of N,N-disubstituted 2-aminothiazolines as a new class of butyrylcholinesterase and carboxylesterase inhibitors.
    Makhaeva GF, Boltneva NP, Lushchekina SV, Serebryakova OG, Stupina TS, Terentiev AA, Serkov IV, Proshin AN, Bachurin SO, Richardson RJ.
    Bioorg Med Chem; 2016 Mar 01; 24(5):1050-62. PubMed ID: 26827140
    [Abstract] [Full Text] [Related]

  • 3. A Series of New Hydrazone Derivatives: Synthesis, Molecular Docking and Anticholinesterase Activity Studies.
    Bozbey İ, Özdemir Z, Uslu H, Özçelik AB, Şenol FS, Orhan İE, Uysal M.
    Mini Rev Med Chem; 2020 Mar 01; 20(11):1042-1060. PubMed ID: 31660824
    [Abstract] [Full Text] [Related]

  • 4. Synthesis of 2-arylhydrazinylidene-3-oxo-4,4,4-trifluorobutanoic acids as new selective carboxylesterase inhibitors and radical scavengers.
    Khudina OG, Makhaeva GF, Elkina NA, Boltneva NP, Serebryakova OG, Shchegolkov EV, Rudakova EV, Lushchekina SV, Burgart YV, Bachurin SO, Richardson RJ, Saloutin VI.
    Bioorg Med Chem Lett; 2019 Dec 01; 29(23):126716. PubMed ID: 31640885
    [Abstract] [Full Text] [Related]

  • 5. Synthesis, Biological Evaluation and Molecular Docking Study of Hydrazone-Containing Pyridinium Salts as Cholinesterase Inhibitors.
    Parlar S, Bayraktar G, Tarikogullari AH, Alptüzün V, Erciyas E.
    Chem Pharm Bull (Tokyo); 2016 Dec 01; 64(9):1281-7. PubMed ID: 27581632
    [Abstract] [Full Text] [Related]

  • 6. Bioactive sulfonyl hydrazones with alkyl derivative: Characterization, ADME properties, molecular docking studies and investigation of inhibition on choline esterase enzymes for the diagnosis of Alzheimer's disease.
    Bilen E, Özdemir Özmen Ü, Çete S, Alyar S, Yaşar A.
    Chem Biol Interact; 2022 Jun 01; 360():109956. PubMed ID: 35452634
    [Abstract] [Full Text] [Related]

  • 7. New piperidine-hydrazone derivatives: Synthesis, biological evaluations and molecular docking studies as AChE and BChE inhibitors.
    Karaman N, Sıcak Y, Taşkın-Tok T, Öztürk M, Karaküçük-İyidoğan A, Dikmen M, Koçyiğit-Kaymakçıoğlu B, Oruç-Emre EE.
    Eur J Med Chem; 2016 Nov 29; 124():270-283. PubMed ID: 27592396
    [Abstract] [Full Text] [Related]

  • 8. Cholinesterase inhibitory activity versus aromatic core multiplicity: a facile green synthesis and molecular docking study of novel piperidone embedded thiazolopyrimidines.
    Basiri A, Murugaiyah V, Osman H, Kumar RS, Kia Y, Hooda A, Parsons RB.
    Bioorg Med Chem; 2014 Jan 15; 22(2):906-16. PubMed ID: 24369842
    [Abstract] [Full Text] [Related]

  • 9. Syntheses, cholinesterases inhibition, and molecular docking studies of pyrido[2,3-b]pyrazine derivatives.
    Hameed A, Zehra ST, Shah SJ, Khan KM, Alharthy RD, Furtmann N, Bajorath J, Tahir MN, Iqbal J.
    Chem Biol Drug Des; 2015 Nov 15; 86(5):1115-20. PubMed ID: 25951978
    [Abstract] [Full Text] [Related]

  • 10. Conjugates of methylene blue with γ-carboline derivatives as new multifunctional agents for the treatment of neurodegenerative diseases.
    Bachurin SO, Makhaeva GF, Shevtsova EF, Boltneva NP, Kovaleva NV, Lushchekina SV, Rudakova EV, Dubova LG, Vinogradova DV, Sokolov VB, Aksinenko AY, Fisenko VP, Richardson RJ, Aliev G.
    Sci Rep; 2019 Mar 19; 9(1):4873. PubMed ID: 30890752
    [Abstract] [Full Text] [Related]

  • 11. Synthesis of novel 6-substituted-3(2H)-pyridazinone-2-acetyl-2-(substituted/-nonsubstituted benzal)hydrazone derivatives and acetylcholinesterase and butyrylcholinesterase inhibitory activities in vitro.
    Utku S, Gökçe M, Orhan I, Sahin MF.
    Arzneimittelforschung; 2011 Mar 19; 61(1):1-7. PubMed ID: 21355440
    [Abstract] [Full Text] [Related]

  • 12. Synthesis, characterization, and molecular docking analysis of novel benzimidazole derivatives as cholinesterase inhibitors.
    Yoon YK, Ali MA, Wei AC, Choon TS, Khaw KY, Murugaiyah V, Osman H, Masand VH.
    Bioorg Chem; 2013 Aug 19; 49():33-9. PubMed ID: 23886696
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of two different cholinesterases by tacrine.
    Ahmed M, Rocha JB, Corrêa M, Mazzanti CM, Zanin RF, Morsch AL, Morsch VM, Schetinger MR.
    Chem Biol Interact; 2006 Aug 25; 162(2):165-71. PubMed ID: 16860785
    [Abstract] [Full Text] [Related]

  • 14. Overview of novel multifunctional agents based on conjugates of γ-carbolines, carbazoles, tetrahydrocarbazoles, phenothiazines, and aminoadamantanes for treatment of Alzheimer's disease.
    Makhaeva GF, Shevtsova EF, Boltneva NP, Lushchekina SV, Kovaleva NV, Rudakova EV, Bachurin SO, Richardson RJ.
    Chem Biol Interact; 2019 Aug 01; 308():224-234. PubMed ID: 31100279
    [Abstract] [Full Text] [Related]

  • 15. Synthesis, structural characterization, docking, lipophilicity and cytotoxicity of 1-[(1R)-1-(6-fluoro-1,3-benzothiazol-2-yl)ethyl]-3-alkyl carbamates, novel acetylcholinesterase and butyrylcholinesterase pseudo-irreversible inhibitors.
    Pejchal V, Štěpánková Š, Pejchalová M, Královec K, Havelek R, Růžičková Z, Ajani H, Lo R, Lepšík M.
    Bioorg Med Chem; 2016 Apr 01; 24(7):1560-72. PubMed ID: 26947959
    [Abstract] [Full Text] [Related]

  • 16. Phthalimide-Derived N-Benzylpyridinium Halides Targeting Cholinesterases: Synthesis and Bioactivity of New Potential Anti-Alzheimer's Disease Agents.
    Saeedi M, Golipoor M, Mahdavi M, Moradi A, Nadri H, Emami S, Foroumadi A, Shafiee A.
    Arch Pharm (Weinheim); 2016 Apr 01; 349(4):293-301. PubMed ID: 26898241
    [Abstract] [Full Text] [Related]

  • 17. Cholinesterase inhibitory triterpenoids from the bark of Garcinia hombroniana.
    Jamila N, Khairuddean M, Yeong KK, Osman H, Murugaiyah V.
    J Enzyme Inhib Med Chem; 2015 Feb 01; 30(1):133-9. PubMed ID: 24666300
    [Abstract] [Full Text] [Related]

  • 18. Structural modifications of 4-aryl-4-oxo-2-aminylbutanamides and their acetyl- and butyrylcholinesterase inhibitory activity. Investigation of AChE-ligand interactions by docking calculations and molecular dynamics simulations.
    Vitorović-Todorović MD, Koukoulitsa C, Juranić IO, Mandić LM, Drakulić BJ.
    Eur J Med Chem; 2014 Jun 23; 81():158-75. PubMed ID: 24836068
    [Abstract] [Full Text] [Related]

  • 19. Synthesis of novel 5-(aroylhydrazinocarbonyl)escitalopram as cholinesterase inhibitors.
    Nisa MU, Munawar MA, Iqbal A, Ahmed A, Ashraf M, Gardener QA, Khan MA.
    Eur J Med Chem; 2017 Sep 29; 138():396-406. PubMed ID: 28688279
    [Abstract] [Full Text] [Related]

  • 20. Probing the mid-gorge of cholinesterases with spacer-modified bivalent quinazolinimines leads to highly potent and selective butyrylcholinesterase inhibitors.
    Chen X, Tikhonova IG, Decker M.
    Bioorg Med Chem; 2011 Feb 01; 19(3):1222-35. PubMed ID: 21232964
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.